Category Archives: (Midwest Communications, Inc. Syndication Interface) Business News (Master Feed)

By Timothy Gardner WASHINGTON, April 29 (Reuters) - U.S. President Donald Trump met with top officials from Chevron and other energy companies on Tuesday to talk about possible steps to calm oil marke...

By Padraic Halpin DUBLIN, April 29 (Reuters) - The head of the world's largest aircraft leasing company, AerCap, said on Wednesday that higher fuel prices have had little impact on the sector so far, ...

By Juveria Tabassum and Svea Herbst-Bayliss April 29 (Reuters) - Lululemon Athletica founder Chip Wilson raised concerns about the struggling athletic-wear maker's appointment of ex-Nike executive Hei...

WASHINGTON, April 29 (Reuters) - New orders for key U.S.-manufactured capital goods increased more than expected in March while shipments of those products surged, suggesting that business spending on...

DUBAI, April 29 (Reuters) - Iran's currency dropped to a record low of 1,810,000 rials to the U.S. dollar on Wednesday, the Iranian Student News Agency (ISNA) said, as demand for foreign exchange that...

By Charlotte Van Campenhout PARIS, April 29 (Reuters) - France's consumer protection authority said on Wednesday that threequarters of the products it tested from major ecommerce platforms last year f...

By Sarita Chaganti Singh and Manoj Kumar NEW DELHI, April 29 (Reuters) - India's economy remains resilient but faces mounting risks from the Middle East conflict, which has disrupted supplies of energ...

By Sahil Pandey April 29 (Reuters) - Medical equipment maker GE HealthCare on Wednesday cut its full-year profit forecast on the back of inflation-driven cost pressures, sending its shares down about ...

By Maria Martinez BERLIN, April 29 (Reuters) - German inflation picked up in April due to surging energy prices fuelled by the war in Iran, data showed on Wednesday, though a drop in core inflation sh...

By Kamal Choudhury and Christy Santhosh April 29 (Reuters) - AbbVie on Wednesday reported better-than-expected quarterly revenue and profit, fueled by demand for newer immunology drugs Skyrizi and Rin...